CCPM
RCUS icon

Cooper Creek Partners Management’s Arcus Biosciences RCUS Stock Holding History

Cooper Creek Partners Management’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-28,342
Closed -$1.15M – 140
2021
Q4 		$1.15M Hold
28,342
– – 0.13% 102
2021
Q3 		$988K Hold
28,342
– – 0.13% 97
2021
Q2 		$778K Hold
28,342
– – 0.2% 95
2021
Q1 		$796K Hold
28,342
– – 0.22% 88
2020
Q4 		$736K Hold
28,342
– – 0.18% 94
2020
Q3 		$486K Hold
28,342
– – 0.12% 96
2020
Q2 		$701K Buy
+28,342
New +$765K 0.18% 97

Other funds holding RCUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

Cooper Creek Partners Management's RCUS Position: Q1 2022 in Review

Cooper Creek Partners Management sold out of Arcus Biosciences (RCUS) in Q1 2022, closing a stake of 28,342 shares — an estimated $1.15M sold.

Cooper Creek Partners Management first reported a position in RCUS in Q2 2020 and held it in 7 quarters. The position peaked at $1.15M in Q4 2021. 157 funds tracked by Wall St. Rank hold RCUS as of Q1 2022.

  • Cooper Creek Partners Management reported no remaining Arcus Biosciences position as of Q1 2022 after selling out during the quarter.
  • Cooper Creek Partners Management sold 28,342 Arcus Biosciences shares in Q1 2022, an estimated $1.15M.
  • Cooper Creek Partners Management first reported a position in Arcus Biosciences in Q2 2020 and held it in 7 quarters.
  • Cooper Creek Partners Management's Arcus Biosciences position peaked at $1.15M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2022.

Based on Cooper Creek Partners Management's 13F filing for Q1 2022, filed 16 May 2022.